Fundraising FoxAllegro Ophthalmics
San Juan Capistrano, US · Founded 2011 · California LLC · 1 known investors
Find your way into Allegro Ophthalmics
286 people in our graph share verified history with the Allegro Ophthalmics team — schools, employers, funds. One of them is your warm intro.
Mohamed Geneadunlockedknows John Park · together at Allegro Ophthalmics (overlapped)
×11knows the team · via Allergan
Founders & leadership
Allegro Ophthalmics was founded in 2011 by Hampar Karageozian and Vicken Karageozian.
VK
Vicken KarageozianCo-founder · Chief Executive Officer and President2018–2026He has led drug development programs through FDA approval, raised over $270 million across multiple biotech ventures, and holds 87 patents while navigating clinical trials, regulatory strategy, and partnerships across ophthalmic pharmaceuticals.
JP
John ParkCo-Founder and Vice PresidentJohn Park is an executive with a background in pharmaceutical product development and drug discovery.
Board
AT
A. Thomas BenderMember of Board of Managers
RB
Robert ByrnesMember of Board of Managers
Investors · 1
Reported raises · per SEC filings
Form D private placements$60.4M disclosed across 6 rounds · 2015–2021
▶$5.4MraisedOct 2021 · 6 investors · PharmaceuticalsRule 506(b)
▶$5.4MraisedOct 2021 · 6 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Vicken KarageozianExecutive Officer, Director
- Rebecca ColbertDirector
- Melvin SaraybaExecutive Officer
- Ronald KurtzDirector
- Marc CarlsonDirector
- Hampar KarageozianDirector
- Stephanie YeeExecutive Officer
- John ParkDirector
- William LinkDirector
- Offering amount
- $6.7M
- Amount sold
- $5.4M
- First sale
- Sep 2021
- Incorporated
- Limited Liability Company, California
- Federal exemptions
- 06b
▶$8.3MraisedOct 2020 · 15 investors · PharmaceuticalsRule 506(b)
▶$8.3MraisedOct 2020 · 15 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Vicken KarageozianExecutive Officer, Director
- Melvin SaraybaExecutive Officer
- John ParkDirector
- Marc CarlsonDirector
- Rebecca ColbertDirector
- Ronald KurtzDirector
- William LinkDirector
- Hampar KarageozianDirector
- Scott CooperExecutive Officer
- Offering amount
- $8.3M
- Amount sold
- $8.3M
- First sale
- Sep 2020
- Incorporated
- Limited Liability Company, California
- Federal exemptions
- 06b
▶$5.3MraisedJan 2020 · 11 investors · PharmaceuticalsRule 506(b)
▶$5.3MraisedJan 2020 · 11 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Scott CooperExecutive Officer
- Melvin SaraybaExecutive Officer
- Rebecca ColbertDirector
- William LinkDirector
- Marc CarlsonDirector
- John ParkExecutive Officer, Director
- Hampar KarageozianDirector
- Vicken KarageozianExecutive Officer, Director
- Ronald KurtzDirector
- Offering amount
- $6.7M
- Amount sold
- $5.3M
- First sale
- Dec 2019
- Incorporated
- Limited Liability Company, California
- Federal exemptions
- 06b
▶$10.3MraisedJan 2019 · 14 investors · PharmaceuticalsRule 506(b)
▶$10.3MraisedJan 2019 · 14 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- John ParkExecutive Officer, Director
- Melvin SaraybaExecutive Officer
- William LinkDirector
- Marc CarlsonDirector
- Vicken KarageozianExecutive Officer, Director
- Scott CooperExecutive Officer
- Ronald KurtzDirector
- Hampar KarageozianDirector
- Offering amount
- $13.5M
- Amount sold
- $10.3M
- First sale
- Dec 2018
- Incorporated
- Limited Liability Company, California
- Federal exemptions
- 06b
▶$10.7MraisedJul 2017 · 17 investors · PharmaceuticalsRule 506(b)
▶$10.7MraisedJul 2017 · 17 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Mark LivingstonDirector
- Lisa KarageozianExecutive Officer, Director
- Melvin SaraybaExecutive Officer
- Scott CooperExecutive Officer
- A. Thomas BenderDirector
- Ron KurtzDirector
- John ParkExecutive Officer, Director
- Vicken KarageozianExecutive Officer, Director
- Robert ByrnesDirector
- Hampar KarageozianExecutive Officer, Director
- William J. LinkDirector
- Offering amount
- $13.7M
- Amount sold
- $10.7M
- First sale
- May 2017
- Incorporated
- Limited Liability Company, California
- Federal exemptions
- 06b
▶$20.3MraisedJan 2015 · 10 investors · PharmaceuticalsRule 506(b)
▶$20.3MraisedJan 2015 · 10 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- John ParkExecutive Officer, Director
- Hampar KarageozianExecutive Officer, Director
- Marc D. KirshbaumExecutive Officer, Director
- A. Thomas BenderDirector
- Robert ByrnesDirector
- Vicken KarageozianExecutive Officer, Director
- Offering amount
- $21.2M
- Amount sold
- $20.3M
- Sales commissions
- $600K
- Proceeds to insiders
- $361.5K
- Placement agents
- Aquilo Partners, L.P.
- First sale
- Jan 2015
- Incorporated
- Limited Liability Company, California, 2011
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who founded Allegro Ophthalmics?
- Allegro Ophthalmics was founded by Hampar Karageozian, Vicken Karageozian in 2011.
- Who are Allegro Ophthalmics's investors?
- Allegro Ophthalmics's investors include Versant Venture AIV Holdings.
- How much funding has Allegro Ophthalmics raised?
- Allegro Ophthalmics has disclosed $60.4M raised across 6 rounds.
- Where is Allegro Ophthalmics headquartered?
- Allegro Ophthalmics is headquartered in San Juan Capistrano, US.